Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
SURG's Cash to Debt is ranked higher than
95% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. SURG: No Debt )
SURG' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.75
SURG's Equity to Asset is ranked higher than
81% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SURG: 0.75 )
SURG' s 10-Year Equity to Asset Range
Min: 0.57   Max: 0.98
Current: 0.75

0.57
0.98
Interest Coverage No Debt
SURG's Interest Coverage is ranked higher than
72% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 234.31 vs. SURG: No Debt )
SURG' s 10-Year Interest Coverage Range
Min: 1.56   Max: 9999.99
Current: No Debt

1.56
9999.99
F-Score: 6
Z-Score: 5.43
M-Score: -3.00
WACC vs ROIC
10.21%
6.02%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 6.60
SURG's Operating margin (%) is ranked higher than
77% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 5.53 vs. SURG: 6.60 )
SURG' s 10-Year Operating margin (%) Range
Min: -8.11   Max: 15
Current: 6.6

-8.11
15
Net-margin (%) 4.40
SURG's Net-margin (%) is ranked higher than
75% of the 456 Companies
in the Global Medical Devices industry.

( Industry Median: 4.05 vs. SURG: 4.40 )
SURG' s 10-Year Net-margin (%) Range
Min: -7.41   Max: 11.01
Current: 4.4

-7.41
11.01
ROE (%) 4.59
SURG's ROE (%) is ranked higher than
72% of the 440 Companies
in the Global Medical Devices industry.

( Industry Median: 5.22 vs. SURG: 4.59 )
SURG' s 10-Year ROE (%) Range
Min: -2.53   Max: 16.86
Current: 4.59

-2.53
16.86
ROA (%) 3.44
SURG's ROA (%) is ranked higher than
75% of the 472 Companies
in the Global Medical Devices industry.

( Industry Median: 2.73 vs. SURG: 3.44 )
SURG' s 10-Year ROA (%) Range
Min: -2.44   Max: 11.03
Current: 3.44

-2.44
11.03
ROC (Joel Greenblatt) (%) 12.82
SURG's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 470 Companies
in the Global Medical Devices industry.

( Industry Median: 9.36 vs. SURG: 12.82 )
SURG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -13.95   Max: 40.77
Current: 12.82

-13.95
40.77
Revenue Growth (3Y)(%) 4.70
SURG's Revenue Growth (3Y)(%) is ranked higher than
74% of the 333 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. SURG: 4.70 )
SURG' s 10-Year Revenue Growth (3Y)(%) Range
Min: -2.6   Max: 50.6
Current: 4.7

-2.6
50.6
EBITDA Growth (3Y)(%) -13.40
SURG's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SURG: -13.40 )
SURG' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 115.4
Current: -13.4

0
115.4
EPS Growth (3Y)(%) -19.50
SURG's EPS Growth (3Y)(%) is ranked higher than
66% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. SURG: -19.50 )
SURG' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 122.4
Current: -19.5

0
122.4
» SURG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

SURG Guru Trades in Q4 2013

Jim Simons 50,701 sh (+299.22%)
Chuck Royce 981,274 sh (+81.86%)
» More
Q1 2014

SURG Guru Trades in Q1 2014

Chuck Royce 1,491,274 sh (+51.97%)
Jim Simons 52,400 sh (+3.35%)
» More
Q2 2014

SURG Guru Trades in Q2 2014

Jim Simons 79,500 sh (+51.72%)
Chuck Royce 1,531,149 sh (+2.67%)
» More
Q3 2014

SURG Guru Trades in Q3 2014

Jim Simons 153,400 sh (+92.96%)
Chuck Royce 1,531,149 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with SURG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 41.40
SURG's P/E(ttm) is ranked higher than
80% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 88.80 vs. SURG: 41.40 )
SURG' s 10-Year P/E(ttm) Range
Min: 5.03   Max: 335.63
Current: 41.4

5.03
335.63
Forward P/E 19.96
SURG's Forward P/E is ranked higher than
90% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 19.96 )
N/A
PE(NRI) 39.80
SURG's PE(NRI) is ranked higher than
81% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 84.40 vs. SURG: 39.80 )
SURG' s 10-Year PE(NRI) Range
Min: 5   Max: 335.63
Current: 39.8

5
335.63
P/B 1.90
SURG's P/B is ranked higher than
86% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 4.18 vs. SURG: 1.90 )
SURG' s 10-Year P/B Range
Min: 0.49   Max: 9.59
Current: 1.9

0.49
9.59
P/S 1.80
SURG's P/S is ranked higher than
80% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. SURG: 1.80 )
SURG' s 10-Year P/S Range
Min: 0.34   Max: 7.18
Current: 1.8

0.34
7.18
PFCF 14.60
SURG's PFCF is ranked higher than
95% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 14.60 )
SURG' s 10-Year PFCF Range
Min: 1.6   Max: 99999999.99
Current: 14.6

1.6
99999999.99
POCF 12.55
SURG's POCF is ranked higher than
91% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 58.93 vs. SURG: 12.55 )
SURG' s 10-Year POCF Range
Min: 1.54   Max: 99999999.99
Current: 12.55

1.54
99999999.99
EV-to-EBIT 23.12
SURG's EV-to-EBIT is ranked higher than
84% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 74.50 vs. SURG: 23.12 )
SURG' s 10-Year EV-to-EBIT Range
Min: -796.9   Max: 153.4
Current: 23.12

-796.9
153.4
Shiller P/E 28.00
SURG's Shiller P/E is ranked higher than
93% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 28.00 )
SURG' s 10-Year Shiller P/E Range
Min: 7.5   Max: 255
Current: 28

7.5
255
Current Ratio 5.71
SURG's Current Ratio is ranked higher than
88% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. SURG: 5.71 )
SURG' s 10-Year Current Ratio Range
Min: 1.73   Max: 30
Current: 5.71

1.73
30
Quick Ratio 4.01
SURG's Quick Ratio is ranked higher than
84% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. SURG: 4.01 )
SURG' s 10-Year Quick Ratio Range
Min: 0.68   Max: 14
Current: 4.01

0.68
14
Days Inventory 196.21
SURG's Days Inventory is ranked higher than
64% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 160.07 vs. SURG: 196.21 )
SURG' s 10-Year Days Inventory Range
Min: 122.69   Max: 332.79
Current: 196.21

122.69
332.79
Days Sales Outstanding 67.22
SURG's Days Sales Outstanding is ranked higher than
77% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 79.24 vs. SURG: 67.22 )
SURG' s 10-Year Days Sales Outstanding Range
Min: 24.57   Max: 96.62
Current: 67.22

24.57
96.62

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 8.00
SURG's Price/Net Current Asset Value is ranked higher than
90% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 8.00 )
SURG' s 10-Year Price/Net Current Asset Value Range
Min: 3.53   Max: 127.5
Current: 8

3.53
127.5
Price/Tangible Book 3.10
SURG's Price/Tangible Book is ranked higher than
83% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 7.44 vs. SURG: 3.10 )
SURG' s 10-Year Price/Tangible Book Range
Min: 1.84   Max: 19.65
Current: 3.1

1.84
19.65
Price/DCF (Projected) 1.10
SURG's Price/DCF (Projected) is ranked higher than
95% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 1.10 )
SURG' s 10-Year Price/DCF (Projected) Range
Min: 0.73   Max: 23.44
Current: 1.1

0.73
23.44
Price/Median PS Value 1.00
SURG's Price/Median PS Value is ranked higher than
83% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. SURG: 1.00 )
SURG' s 10-Year Price/Median PS Value Range
Min: 0.23   Max: 5.11
Current: 1

0.23
5.11
Price/Graham Number 2.40
SURG's Price/Graham Number is ranked higher than
87% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. SURG: 2.40 )
SURG' s 10-Year Price/Graham Number Range
Min: 0.82   Max: 14.29
Current: 2.4

0.82
14.29
Earnings Yield (Greenblatt) 4.30
SURG's Earnings Yield (Greenblatt) is ranked higher than
84% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. SURG: 4.30 )
SURG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 18.4
Current: 4.3

0.7
18.4
Forward Rate of Return (Yacktman) -6.07
SURG's Forward Rate of Return (Yacktman) is ranked higher than
64% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: 7.58 vs. SURG: -6.07 )
SURG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -9.6   Max: 1024
Current: -6.07

-9.6
1024

Analyst Estimate

Jul15 Jul16
Revenue(Mil) 74 85
EPS($) 0.16 0.23
EPS without NRI($) 0.16 0.23

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Synergetics USA Inc is a Delaware corporation incorporated on June 2, 2005 in connection with the reverse merger of Synergetics, Inc. and Valley Forge Scientific Corp. The Company is a supplier of precision surgical devices. It develops, manufactures, and markets disposable and durable equipment for use in ophthalmologic, neurosurgical, and other microsurgical applications. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits and the delivery of various energy modalities for the performance of surgery, including: laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. It's ophthalmic and vitreoretinal surgical devices and equipment compete against manufacturers of similar products, including those sold by its major competitors, Alcon, Bausch & Lomb, Inc., Dutch Ophthalmic Research Center and Iridex. The Company is subject to macro-economic fluctuations in the United States, the countries of Europe and the economies of other countries throughout the world. Medical device companies are subject to rigorous regulation, including by the FDA and numerous other federal, state and foreign governmental authorities.
» More Articles for SURG

Headlines

Articles On GuruFocus.com
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2015 Results Dec 01 2014 
Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2014 Results Oct 15 2014 
Synergetics USA: A Growth Story Amidst an Aging Population Aug 30 2012 
Synergetics Up 30% after Approval for Eye Surgery Device Jun 28 2012 
Synergetics USA Inc. (SURG) EVP & COO Kurt W Jr Gampp sells 43,000 Shares Mar 15 2011 
Weekly CFO Buys Highlight: CNLG, SIFID, FUL, SURG, TYL Jan 15 2011 
Synergetics USA Inc. (SURG) President and CEO David M Hable sells 17,000 Shares Jan 07 2011 
Weekly CFO Buys Highlight: COIN, INTC, SURG, IBCA, AUMN Oct 24 2010 
Synergetics USA, Inc. Announces 3 Month Extension of Current Agreements with Codman & Shurtleff, Inc Jan 07 2009 


More From Other Websites
AngioDynamics Celerity System Gets Expanded FDA Approval - Analyst Blog Jan 30 2015
FDA OKs DexCom Glucose Monitoring System with Share App - Analyst Blog Jan 28 2015
Abiomed Q3 Earnings Impress; Impella RP Gets FDA Approval - Analyst Blog Jan 28 2015
Accuray (ARAY) Q2 Loss Wider than Expected, Revenues Lag - Analyst Blog Jan 28 2015
Quality Systems Beats Q3 Earnings on Revenue Strength - Analyst Blog Jan 27 2015
Falling Earnings Estimates Signal Weakness Ahead for Accuray (ARAY) - Tale of the Tape Jan 27 2015
Echo Therapeutics Restores Pact with MTIA, Issues Patent - Analyst Blog Jan 22 2015
Greatbatch (GB) Rides High on Strategic Investments - Analyst Blog Jan 22 2015
Cantel Medical's MINNCARE HD Disinfectant Wins FDA Nod - Analyst Blog Jan 21 2015
Exactech Acquires Surgical Technology Partner BlueOrtho - Analyst Blog Jan 21 2015
NextGen Practice Management Wins EHNAC Accreditation - Analyst Blog Jan 21 2015
IRadimed (IRMD) Now a Strong Buy on Positive 2015 Outlook - Analyst Blog Jan 21 2015
Synergetics USA (SURG) in Focus: Stock Rises 5.5% - Tale of the Tape Jan 21 2015
Can the Rally in Synergetics (SURG) Shares Continue? - Tale of the Tape Jan 21 2015
IDEXX's SDMA Test: Key to Kidney Disease Diagnosis in Pets - Analyst Blog Jan 20 2015
Teleflex's Protected Catheters Potent in Infection Reduction - Analyst Blog Jan 19 2015
IDEXX Up on Record Instrument Placements, Raises 2014 View - Analyst Blog Jan 19 2015
Greatbatch Reports Preliminary 2014 Results, Guides 2015 - Analyst Blog Jan 16 2015
HeartWare Announces Preliminary Q4, 2014 Revenue Results - Analyst Blog Jan 14 2015
Intuitive Surgical Announces Preliminary Q4 & FY14 Results - Analyst Blog Jan 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK